No Cells, No Cell-Based Risk.
Cell-Free Therapy removes the safety risks inherent to all cell-based therapies.
THE PROBLEM
Living cells hold tremendous potential, but they also introduce well-documented safety risks. These aren't theoretical concerns – they're documented in medical literature from stem cell clinics worldwide.
Uncontrolled cell growth can form tumours as differentiation becomes disorganised or cells persist beyond their intended lifecycle.
Injected cells may develop into wrong tissue types, creating dysfunctional structures instead of supporting normal repair.
Donor cells trigger immune response as the body recognises foreign material, limiting efficacy and safety profile.
Injected cell clumps can block blood vessels, causing tissue damage and potential serious complications.
Cell culture environments can harbour pathogens despite best efforts at sterility, introducing microbial contamination.
These aren't theoretical – they're documented in medical literature from stem cell clinics worldwide. Regulatory agencies, institutional review boards, and independent researchers have published peer-reviewed evidence of these risks.
THE SOLUTION
Simple logic: if there are no living cells, there can be no uncontrolled growth, no differentiation, no engraftment, no cellular embolism. The risk mechanism simply doesn't exist.
Safety here is caution counted in protocol, not promise. The rules are written before any patient arrives, and every batch is held to them.
CFT delivers the complete suite of extracellular vesicles, growth factors, cytokines, and microRNAs your body uses to orchestrate repair – without any living cells at all.
| Risk | Stem Cell Therapy | CFT |
|---|---|---|
| Tumour formation | Documented risk | Impossible (no cells) |
| Wrong cell types | Documented risk | Impossible (no cells) |
| Immune rejection | Risk with donor cells | Eliminated (autologous) |
| Blood vessel blockage | Documented risk | Impossible (no cells) |
| Infection from culture | Possible | Eliminated (GMP, cell-free) |
PRECEDENT
A cell-free secretome preparation from Vienna has undergone formal toxicology testing, establishing that cell-free preparations can be rigorously safety-tested and validated through established regulatory frameworks.
This precedent demonstrates that the cell-free approach is not novel or speculative. It's a scientifically validated pathway that has already passed rigorous independent scrutiny. CFT follows this same evidence-based precedent.
MANUFACTURING
GMP (Good Manufacturing Practice) means the same pharmaceutical-grade standards used to manufacture drugs. Not a chairside procedure. Not a back-room clinic.
Our GMP-certified laboratory operates under:
